Skip Navigation

WALS: Rare Retinoblastoma Contributed Over 50 Years to Understanding Cancer : Can We Now Reach Every Child?

Air date: Wednesday, December 18, 2024, 2:00:00 PM
Time displayed is Eastern Time, Washington DC Local
iCalendar: Add event to iCalendar Add an upcoming event to your calendar.
Description: Brenda Gallie is Professor in Medical Biophysics, Molecular Genetics, and Ophthalmology. She directs the Retinoblastoma Program at the Hospital for Sick Children. She received The Order of Ontario and Membership, Order of Canada for delivering personalized medicine and predictive genomic studies to families. To address the global disparity of cancer care and outcomes, she developed point-of-care cancer site-specific databases, now supporting global collaboration and treatment guidelines. LECTURE SUMMARY: eCancerCareRB (eCCRB) has facilitated retinoblastoma circle of care communication and research at SickKids since 2001 by collecting and visually displaying point-of-care retinoblastoma data, including fundus drawings. Updated on a secure Microsoft Azure environment, DEPICT HEALTH (DEPICT) will extend eCCRB worldwide with inclusion of families. Access to eCCRB historic propensity-matched controls in Phase I study of sustained-release of chemotherapy (Chemoplaque), revealed sustained response of intraocular retinoblastoma with minimal toxicity. For ALL children affected by retinoblastoma, DEPICT can support communication and evidence-based care in a learning health system.

For more information go to https://oir.nih.gov/wals/current-lecture-season
Author: Brenda Gallie MD, FRCSC, CM, OOnt
Runtime: 1 hour